Characterization of Tumor Angiogenesis in Rat Brain Using Iron-Based Vessel Size Index MRI in Combination with Gadolinium-Based Dynamic Contrast-Enhanced MRI
Open Access
- 8 July 2009
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 29 (10), 1714-1726
- https://doi.org/10.1038/jcbfm.2009.86
Abstract
This study aimed at combining an iron-based, steady-state, vessel size index magnetic resonance imaging (VSI MRI) approach, and a gadolinium (Gd)-based, dynamic contrast-enhanced MRI approach (DCE MRI) to characterize tumoral microvasculature. Rats bearing an orthotopic glioma (C6, n=14 and RG2, n=6) underwent DCE MRI and combined VSI and DCE MRI 4 h later, at 2.35 T. Gd-DOTA (200 μmol of Gd per kg) and ultrasmall superparamagnetic iron oxide (USPIO) (200 μmol of iron per kg) were used for DCE and VSI MRI, respectively. C6 and RG2 gliomas were equally permeable to Gd-DOTA but presented different blood volume fractions and VSI, in good agreement with histologic data. The presence of USPIO yielded reduced Ktransvalues. The Ktransvalues obtained with Gd-DOTA in the absence and in the presence of USPIO were well correlated for the C6 glioma but not for the RG2 glioma. It was also observed that, within the time frame of DCE MRI, USPIO remained intravascular in the C6 glioma whereas it extravasated in the RG2 glioma. In conclusion, VSI and DCE MRI can be combined provided that USPIO does not extravasate with the time frame of the DCE MRI experiment. The mechanisms at the origin of USPIO extravasation remain to be elucidated.Keywords
This publication has 41 references indexed in Scilit:
- Assessment of blood volume, vessel size, and the expression of angiogenic factors in two rat glioma models: a longitudinal in vivo and ex vivo studyNMR in Biomedicine, 2008
- A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: The finite perturber methodNeuroImage, 2008
- Improved k‐space trajectory measurement with signal shiftingMagnetic Resonance in Medicine, 2007
- AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma PatientsCancer Cell, 2007
- Shutter‐speed analysis of contrast reagent bolus‐tracking data: Preliminary observations in benign and malignant breast diseaseMagnetic Resonance in Medicine, 2005
- Central nervous system inflammatory response after cerebral infarction as detected by magnetic resonance imagingNMR in Biomedicine, 2004
- In vivo assessment of tumoral angiogenesisMagnetic Resonance in Medicine, 2004
- Imaging Experimental Brain Tumors with 1-Aminocyclopentane Carboxylic Acid and Alpha-Aminoisobutyric Acid: Comparison to Fluorodeoxyglucose and Diethylenetriaminepentaacetic Acid in Morphologically Defined Tumor RegionsJournal of Cerebral Blood Flow & Metabolism, 1997
- Quantification of regional blood volumes by rapid T1 mappingMagnetic Resonance in Medicine, 1993
- Significance Tests Which May be Applied to Samples from Any PopulationsJournal of the Royal Statistical Society Series B: Statistical Methodology, 1937